The U.S. Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) has awarded an indefinite delivery, indefinite quantity (IDIQ) contract to Bavarian Nordic, Inc. to provide a variety of pediatric vaccines. The $28.7 million contract has a period of performance from April 1, 2024 to March 31, 2025 and will support the CDC's Immunization Awardees program and Vaccines for Children program.
The solicitation requested offers for 27 different pediatric vaccines, with specified minimum and maximum quantities for each. The vaccines must meet a 12-month minimum shelf life and be licensed by the FDA. Bavarian Nordic will deliver the vaccines F.O.B. destination to the 50 U.S. states and territories. The contract does not utilize any small business set-asides, as it is a multiple-award IDIQ vehicle open to all responsible sources. In addition to this IDIQ contract, Bavarian Nordic holds multiple Federal Supply Schedule contracts with the CDC and Department of Agriculture to provide pharmaceuticals, drugs, and vaccines on an as-needed basis.
Generated 10/20/24, 12:00 AM